J P Morgan Chase & Co set a €25.00 ($29.76) price objective on Evonik Industries (FRA:EVK) in a research note published on Tuesday, November 14th. The brokerage currently has a sell rating on the stock.
A number of other equities analysts have also recently issued reports on the company. Goldman Sachs Group set a €29.00 ($34.52) price objective on Evonik Industries and gave the company a neutral rating in a report on Monday, November 6th. Commerzbank set a €39.00 ($46.43) target price on Evonik Industries and gave the stock a buy rating in a report on Thursday, November 9th. Nord/LB set a €31.00 ($36.90) target price on Evonik Industries and gave the stock a neutral rating in a report on Friday, November 3rd. Berenberg Bank set a €37.00 ($44.05) target price on Evonik Industries and gave the stock a buy rating in a report on Tuesday, November 7th. Finally, Sanford C. Bernstein set a €35.00 ($41.67) price target on Evonik Industries and gave the stock a buy rating in a research report on Friday, November 3rd. One research analyst has rated the stock with a sell rating, eight have given a hold rating and nine have issued a buy rating to the stock. The company has a consensus rating of Hold and a consensus target price of €33.38 ($39.73).
Shares of Evonik Industries (FRA EVK) traded up €0.09 ($0.11) during trading on Tuesday, hitting €31.50 ($37.50). The stock had a trading volume of 1,938 shares. Evonik Industries has a 12-month low of €25.74 ($30.64) and a 12-month high of €32.97 ($39.25).
TRADEMARK VIOLATION WARNING: “Evonik Industries (FRA:EVK) Given a €25.00 Price Target by J P Morgan Chase & Co Analysts” was originally published by BBNS and is the property of of BBNS. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://baseballnewssource.com/markets/evonik-industries-ag-evk-given-a-25-00-price-target-by-j-p-morgan-chase-co-analysts/1782236.html.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries AG and related companies with our FREE daily email newsletter.